Cerus Corporation (NASDAQ:CERS) said on Wednesday that the company received CE mark approval for its illumination device, the ...

Cerus Corporation has obtained CE mark approval for its INT200, a light-emitting diode (LED)-based illumination device, for ...

Johnson & Johnson MedTech (NYSE: JNJ) announced new regulatory nods for multiple orthopedic technology offerings.

Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood System for platelets and plasma under ...

In Part 2 of our ‘Battery Shorts’ series, we look at the conformity assessment and CE marking requirements under the new European Union ...

Patients treated with hyperopic SMILE, which received a CE mark in 2024, show promising results, according to a speaker at ...

For years, medtech firms around the globe (and certainly European companies) introduced their products in Europe, which requires obtaining a CE ...

RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against ...

Cerus (CERS) announced the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood System ...

Cerus Corporation has obtained CE mark approval for its INT200, a light-emitting diode (LED)-based illumination device, for the Intercept Blood System for platelets and plasma. This approval ...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus ...